Theratechnologies' leading product, EGRIFTA®, is available in CANADA and in the UNITED STATES 

EGRIFTA is a trademark of Theratechnologies Inc.



Investigational Agent

Ibalizumab Expanded Access Program (EAP)

You are about to leave Theratechnologies’ website and you will be redirected to an independent website not owned by Theratechnologies. 
Therefore, we disclaim any and all liability in connection with such website.